Skip to main content
Erschienen in: International Ophthalmology 11/2020

01.07.2020 | Original Paper

Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity

verfasst von: Emrah Utku Kabatas, Serdar Ozates

Erschienen in: International Ophthalmology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We sought to assess the risk factors associated with avascular fibrous membrane development in patients with retinopathy of prematurity (ROP).

Methods

This retrospective, cross-sectional study included premature infants diagnosed with ROP. Gestational age, birth weight, stage and zone of the ROP, the presence of plus disease, and laser photocoagulation (LP) application were noted for each patient. Location, extension, development time, vanishing time of the avascular fibrous membrane, and associated complications were also noted. Patients who developed avascular fibrous membrane formed the membrane group (n = 38) and those who did not develop avascular fibrous membrane formed the control group (n = 208).

Results

Mean gestational age and birth weight did not differ between the groups (p = 0.897 and p = 0.343). ROP developed significantly earlier in the control group than in the membrane group (p < 0.001). The patients in the control group underwent LP treatment significantly earlier than did patients in the membrane group (p < 0.001). Regression analysis showed that higher postmenstrual age at the time of ROP diagnosis increased the risk of avascular fibrous membrane development by up to 1.6-fold (p = 0.002; 95% CI 1.2–2.3) and later LP treatment was associated with a 3.3-fold increased risk of avascular fibrous membrane development (p = 0.003; 95% CI 1.5–7.3).

Conclusions

Late-onset ROP and later LP treatment were found to be associated with an increased risk of avascular fibrous membrane development in patients with ROP.
Literatur
1.
Zurück zum Zitat Ophthalmology AAoPSo (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189–195CrossRef Ophthalmology AAoPSo (2013) Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131:189–195CrossRef
2.
Zurück zum Zitat Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 (discussion 248–250)PubMedPubMedCentral Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 (discussion 248–250)PubMedPubMedCentral
3.
Zurück zum Zitat Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394–400CrossRef Sood BG, Madan A, Saha S, Schendel D, Thorsen P, Skogstrand K, Hougaard D, Shankaran S, Carlo W (2010) Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67:394–400CrossRef
4.
Zurück zum Zitat Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236PubMedPubMedCentral Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236PubMedPubMedCentral
5.
Zurück zum Zitat Zhao S, Overbeek PA (2001) Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol 237:45–53CrossRef Zhao S, Overbeek PA (2001) Elevated TGFbeta signaling inhibits ocular vascular development. Dev Biol 237:45–53CrossRef
6.
Zurück zum Zitat Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278–283CrossRef Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J (2002) Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 109:278–283CrossRef
7.
Zurück zum Zitat Group ETfRoPC (2006) Thef54098structural findings at age 2 years. Br J Ophthalmol 90:1378CrossRef Group ETfRoPC (2006) Thef54098structural findings at age 2 years. Br J Ophthalmol 90:1378CrossRef
8.
Zurück zum Zitat Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492–497CrossRef Terasaki H, Hirose T (2003) Late-onset retinal detachment associated with regressed retinopathy of prematurity. Jpn J Ophthalmol 47:492–497CrossRef
9.
Zurück zum Zitat Lee BJ, Kim JH, Heo H, Yu YS (2012) Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26:903–909 (quiz 910)CrossRef Lee BJ, Kim JH, Heo H, Yu YS (2012) Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 26:903–909 (quiz 910)CrossRef
10.
Zurück zum Zitat Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 5:35–46CrossRef Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N (2016) Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 5:35–46CrossRef
11.
Zurück zum Zitat Lee AC, Maldonado RS, Sarin N, O’Connell RV, Wallace DK, Freedman SF, Cotten M, Toth CA (2011) Macular features from spectral domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31:1470CrossRef Lee AC, Maldonado RS, Sarin N, O’Connell RV, Wallace DK, Freedman SF, Cotten M, Toth CA (2011) Macular features from spectral domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 31:1470CrossRef
12.
Zurück zum Zitat Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT (2018) Vitreous bands identified by handheld spectral-domain optical coherence tomography among premature infants. JAMA Ophthalmol 136:753–758CrossRef Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT (2018) Vitreous bands identified by handheld spectral-domain optical coherence tomography among premature infants. JAMA Ophthalmol 136:753–758CrossRef
Metadaten
Titel
Risk factors associated with avascular fibrous membrane in patients with retinopathy of prematurity
verfasst von
Emrah Utku Kabatas
Serdar Ozates
Publikationsdatum
01.07.2020
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 11/2020
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01484-4

Weitere Artikel der Ausgabe 11/2020

International Ophthalmology 11/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.